Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,553 across all filing types
Latest filing 2018-02-05 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Notice of Investor/Analyst Briefing - 2018 Half Year Results 1
Regulatory Filings
2018-02-05 English
Company Secretary Appointment/Resignation 1 page 66
Regulatory Filings
2017-12-20 English
CSL Appoints New Directors 3 pages 47.4KB
Regulatory Filings
2017-12-12 English
R&D Investor Briefing 96 pages 2.4MB
Regulatory Filings
2017-12-04 English
Appendix 3B 8 pages 378.6KB
Regulatory Filings
2017-12-04 English
PGC: Acquisition of Immunohaematology Business 2 pages 616.6KB
Regulatory Filings
2017-11-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.